Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial.

Healey JS, Gula LJ, Birnie DH, Sterns L, Connolly SJ, Sapp J, Crystal E, Simpson C, Exner DV, Kus T, Philippon F, Wells G, Tang AS.

J Cardiovasc Electrophysiol. 2012 Dec;23(12):1313-6. doi: 10.1111/j.1540-8167.2012.02393.x. Epub 2012 Jul 12.

PMID:
22788915
2.

Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.

Sadoul N, Defaye P, Mouton E, Bizeau O, Dupuis JM, Blangy H, Delarche N, Blanc JJ, Lazarus A; LEADER registry investigators.

Arch Cardiovasc Dis. 2013 Nov;106(11):562-9. doi: 10.1016/j.acvd.2013.07.002. Epub 2013 Nov 4.

3.
4.

Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.

Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D'Acri MG, Klersy C, Gasparini M; SAFE-ICD Study Investigators.

J Am Coll Cardiol. 2012 Sep 11;60(11):981-7. doi: 10.1016/j.jacc.2012.05.014. Epub 2012 Aug 1.

5.

Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).

Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS; RAFT Investigators.

Circ Heart Fail. 2012 Sep 1;5(5):566-70. Epub 2012 Aug 14.

6.

Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).

Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, Kautzner J, O'Hara G, VanErven L, Gadler F, Pogue J, Appl U, Gilkerson J, Pochet T, Stein KM, Merkely B, Chrolavicius S, Meeks B, Foldesi C, Thibault B, Connolly SJ; Shockless IMPLant Evaluation [SIMPLE] investigators.

Lancet. 2015 Feb 28;385(9970):785-91. doi: 10.1016/S0140-6736(14)61903-6. Epub 2015 Feb 23.

PMID:
25715991
7.

Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.

Essebag V, Joza J, Birnie DH, Sapp JL, Sterns LD, Philippon F, Yee R, Crystal E, Kus T, Rinne C, Healey JS, Sami M, Thibault B, Exner DV, Coutu B, Simpson CS, Wulffhart Z, Yetisir E, Wells G, Tang AS.

Circ Arrhythm Electrophysiol. 2015 Feb;8(1):152-8. doi: 10.1161/CIRCEP.114.001997. Epub 2014 Nov 23.

8.

Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry.

Healey JS, Birnie DH, Lee DS, Krahn AD, Crystal E, Simpson CS, Dorian P, Chen Z, Cameron D, Verma A, Connolly SJ, Gula LJ, Lockwood E, Nair G, Tu JV; Ontario ICD Database Investigators.

J Cardiovasc Electrophysiol. 2010 Dec;21(12):1344-8. doi: 10.1111/j.1540-8167.2010.01850.x.

PMID:
20662988
9.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
10.

ICD implantation without intraoperative testing does not increase the rate of system modifications and does not impair defibrillation efficacy tested in follow-up.

Bastian D, Kracker S, Pauschinger M, Göhl K.

Herzschrittmacherther Elektrophysiol. 2013 Jun;24(2):125-30. doi: 10.1007/s00399-013-0267-5. Epub 2013 Jun 7.

PMID:
23744101
11.

The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation.

Healey JS, Hohnloser SH, Glikson M, Neuzner J, Viñolas X, Mabo P, Kautzner J, O'Hara G, Van Erven L, Gadler F, Appl U, Connolly SJ.

Am Heart J. 2012 Aug;164(2):146-52. doi: 10.1016/j.ahj.2012.05.007.

PMID:
22877799
12.

The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.

Bänsch D, Bonnemeier H, Brandt J, Bode F, Svendsen JH, Felk A, Hauser T, Wegscheider K; NORDIC ICD Trial Investigators.

Europace. 2015 Jan;17(1):142-7. doi: 10.1093/europace/euu161. Epub 2014 Aug 8.

PMID:
25107947
13.

Does defibrillation testing influence outcomes after CRT-D implantation? A cause-of-death analysis from the DAI-PP study.

Perrin T, Mechulan A, Boveda S, Beganton F, Defaye P, Sadoul N, Piot O, Klug D, Gras D, Perier MC, Algalarrondo V, Bordachar P, Babuty D, Fauchier L, Leclercq C, Marijon E, Deharo JC; DAI-PP Investigators.

Int J Cardiol. 2016 Oct 15;221:951-6. doi: 10.1016/j.ijcard.2016.06.189. Epub 2016 Jun 30.

PMID:
27441474
15.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

16.

Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial.

Vamos M, Healey JS, Wang J, Duray GZ, Connolly SJ, van Erven L, Vinolas X, Neuzner J, Glikson M, Hohnloser SH.

Heart Rhythm. 2016 Feb;13(2):504-10. doi: 10.1016/j.hrthm.2015.11.009. Epub 2015 Nov 11.

PMID:
26569461
17.

Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.

Auricchio A, Metra M, Gasparini M, Lamp B, Klersy C, Curnis A, Fantoni C, Gronda E, Vogt J; Multicenter Longitudinal Observational Study (MILOS) Group.

Am J Cardiol. 2007 Jan 15;99(2):232-8. Epub 2006 Nov 17.

PMID:
17223424
18.

Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.

Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO.

Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018. Epub 2012 Jun 15.

19.

Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.

Curtis AB, Cannom DS, Bigger JT Jr, DiMarco JP, Estes NA 3rd, Steinman RC, Parides MK.

Am Heart J. 1997 Nov;134(5 Pt 1):787-98.

PMID:
9398090
20.

Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.

Barsheshet A, Goldenberg I, Moss AJ, Huang DT, Zareba W, McNitt S, Klein HU, Guetta V.

J Cardiovasc Electrophysiol. 2011 Nov;22(11):1237-42. doi: 10.1111/j.1540-8167.2011.02096.x. Epub 2011 May 26.

PMID:
21615813

Supplemental Content

Support Center